Patients with PAH have decreased pulmonary expression of eNOS and decreased levels of NO in exhaled air, raising the possibility that decreased NO synthesis contributes to the rise in PVR [8, 9]. This evidence concerns the gene NOS3 and pulmonary arterial hypertension.